Oxford Biomedica - logo

Oxford Biomedica - Company & Market Research Reports


Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Gene Therapy for Age-related Macular Degeneration - A Pipeline Analysis Report - Product Thumbnail Image

Gene Therapy for Age-related Macular Degeneration - A Pipeline Analysis Report

  • Report
  • 71 Pages
From
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016 - Product Thumbnail Image

TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016

  • Report
  • 388 Pages
From
Active Immunization for Unconventional Indications Report - Product Thumbnail Image

Active Immunization for Unconventional Indications Report

  • Report
  • 166 Pages
From
Ophthalmology Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Ophthalmology Drug Development Pipeline Review, 2016

  • Report
  • 633 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview - Product Thumbnail Image

Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview

  • Report
  • 208 Pages
From
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities - Product Thumbnail Image

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

  • Report
  • 225 Pages
Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Mucopolysaccharidosis III (Sanfilippo syndrome) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 89 Pages
From
T-cell Immunotherapy: Clinical Trial Tracker - Product Thumbnail Image

T-cell Immunotherapy: Clinical Trial Tracker

  • Clinical Trials
From
Ovarian Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H2 2017

  • Report
  • 2232 Pages
From
Ovarian Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2017

  • Report
  • 2027 Pages
From
Epithelial Ovarian Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Review, H2 2016

  • Report
  • 507 Pages
From
Epithelial Ovarian Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Review, H1 2016

  • Report
  • 479 Pages
From
Epithelial Ovarian Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Epithelial Ovarian Cancer - Pipeline Review, H2 2015

  • Report
  • 450 Pages
From
Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030 - Product Thumbnail Image

Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030

  • Report
  • 292 Pages
From
Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026 - Product Thumbnail Image

Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026

  • Report
  • 228 Pages
From
Age Related Macular Degeneration - Pipeline Review, H2 2017 - Product Thumbnail Image

Age Related Macular Degeneration - Pipeline Review, H2 2017

  • Report
  • 537 Pages
From
Wet AMD- Pipeline Insight, 2018 - Product Thumbnail Image

Wet AMD- Pipeline Insight, 2018

  • Drug Pipelines
  • 106 Pages
From
Retinal Degeneration - Pipeline Insight, 2018 - Product Thumbnail Image

Retinal Degeneration - Pipeline Insight, 2018

  • Drug Pipelines
  • 217 Pages
From
Loading Indicator
adroll